Coagulopathy and COVID-19
EURASIAN JOURNAL OF PULMONOLOGY, vol.22, no.4, pp.67-69, 2020 (ESCI, TRDizin)
- Publication Type: Article / Review
- Volume: 22 Issue: 4
- Publication Date: 2020
- Doi Number: 10.4103/ejop.ejop_49_20
- Journal Name: EURASIAN JOURNAL OF PULMONOLOGY
- Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
- Page Numbers: pp.67-69
- Keywords: COVID-19, coagulopathy, disseminated intravascular coagulation, SEPSIS
- Bursa Uludag University Affiliated: Yes
Abstract
Caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), coronavirus disease 2019 (COVID-19) is a potentially fatal disease as a global public health issue. Several mechanisms may be involved in mortality. One of these is coagulopathy and disseminated intravascular coagulation caused by SARS-CoV-2. When patients have coagulation disorders, treatment becomes more challenging and mortality rate increases accordingly. The aim of this article is to review the potential mechanisms of coagulopathy in COVID-19 in light of literature data.